SCHEMBL2045248

SCHEMBL2045248

N#CS(=O)(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.50
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TSHR P16473 2/20 0.46
CA12 O43570 1/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
PLA2G7 Q13093 1/20 0.46
CA9 Q16790 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
DUSP3 P51452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27888124 1.00 HTR6 (0.50) HTR6CA1CA2ALDH1A1HSD17B10
Ammonia Solution, Strong SCHEMBL27543858 0.97 HTR6 (0.48) HTR6CA1CA2ALDH1A1HSD17B10
Iodobenzene SCHEMBL28794484 0.89 HTR6 (0.41) HTR6CA1CA2ALDH1A1HSD17B10
Chlorobenzene SCHEMBL27834015 0.89 TSHR (0.46) HTR6CA1CA2ALDH1A1HSD17B10
SCHEMBL10656231 0.78 HTR6 (0.55) HTR6CA1CA2ALDH1A1HSD17B10
SCHEMBL7124034 0.76 HTR6 (0.52) HTR6CA1CA2ALDH1A1HSD17B10
SCHEMBL14018160 0.75 MMP2 (0.45) CA1CA2ALDH1A1CA12CA9
SCHEMBL118977 0.75 GAA (0.54) CA1CA2ALDH1A1HSD17B10TDP1
SCHEMBL12017078 0.75 CA2 (0.50) CA1CA2CA12CA9CA14
SCHEMBL9273311 0.75 ALDH1A1 (0.54) CA1CA2ALDH1A1HSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903192-A Preparation method of 3-methoxy isoquinoline compound intermediate 上海相辉医药科技有限公司 2024-04-19 CN claimed
US-20230242494-A1 MALONITRILE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-08-03 US claimed
EP-4153577-A1 NEW MALONITRILE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-03-29 EP claimed
CN-115551837-A Novel malononitrile derivatives 豪夫迈·罗氏有限公司 2022-12-30 CN claimed
US-11326015-B1 Cyanate ester resin THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2022-05-10 US claimed
WO-2021233854-A1 NEW MALONITRILE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2021-11-25 WO claimed
CN-110234423-A It is capable of the method for the detonation of material of detonation for avoiding and extinguishing 拜耳股份公司 2019-09-13 CN claimed
CN-106279167-A Matrine compound derivative and preparation method and application thereof 中国医学科学院医药生物技术研究所 2017-01-04 CN claimed
CN-102659783-B N-substituted sophora flavescens olefine acid derivative as well as preparation method and application thereof INST MEDICINAL BIOTECHNOLOGY 2015-04-22 CN claimed
CN-100406433-C Process for the cyanation of aldehydes KING S COLLEGE LONDON (GB) 2008-07-30 CN claimed
EP-1543156-A4 DETECTION OF CHEMICAL LIGATION USING FLUORESCENCE QUENCHING LEAVING GROUPS UNIV LELAND STANFORD JUNIOR (US) 2005-12-21 EP claimed
EP-1543156-A2 DETECTION OF CHEMICAL LIGATION USING FLUORESCENCE QUENCHING LEAVING GROUPS The Board of Trustees of the Leland Stanford Junior University (US) 2005-06-22 EP claimed
US-20040259102-A1 DETECTION OF CHEMICAL LIGATION USING FLUORESCENCE QUENCHING LEAVING GROUPS STANFORD UNIVERSITY (US) 2004-12-23 US claimed
EP-0926136-B1 Process for producing and method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one KURARAY CO (JP) 2004-05-12 EP claimed
WO-2004010101-A2 DETECTION OF CHEMICAL LIGATION USING FLUORESCENCE QUENCHING LEAVING GROUPS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-01-29 WO claimed
EP-1090013-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP claimed
WO-1999067255-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-12-29 WO claimed
EP-0926136-A2 Process for producing and method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one KURARAY CO., LTD. (JP) 1999-06-30 EP claimed
US-4386935-A Process for producing discharge reserve prints on textile materials with amino-azo-benzene dyes CASSELLA AKTIENGESELLSCHAFT (DE) 1983-06-07 US claimed
US-4175175-A POLYSULFONES, POLYSULFONAMIDES UNION CARBIDE CORPORATION (US) 1979-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11326015-B1 Cyanate ester resin TH, TYR, LPO HTR6 617/4885CA1 1316/4885CA2 1697/4885
US-20230242494-A1 MALONITRILE DERIVATIVES MAL2, ME1, C5 HTR6 3678/4885CA1 2583/4885CA2 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.